Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors
Drug Development Research · 2023-04 · 84 (2) · 275-295
DOI: 10.1002/ddr.22031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 04.01.2023. Verfasst von Feyzi Sinan Tokalı und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Turkey. Hauptthemen laut MEDLINE: Acetic Acid, Aldehyde Reductase. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 120 Literaturangaben.
Abstract (Originalsprache)
Aldose reductase (AR) is a crucial enzyme of the polyol pathway through which glucose is metabolized under conditions of hyperglycemia related to diabetes. A series of novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring ( 1–22 ) was synthesized and tested for in vitro AR inhibitory effect. All the target compounds exhibited nanomolar activity against the target enzyme, and all compounds displayed higher activity as compared to the reference drug epalrestat. Among them, Compound 19 , named 2‐(4‐[(2‐[(4‐methylpiperazin‐1‐yl)methyl]‐4‐oxoquinazolin‐3(4 H )‐ylimino)methyl]phenoxy)acetic acid, displayed the strongest inhibitory effect with a K I value of 61.20 ± 10.18 nM. Additionally, these compounds were investigated for activity against L929, nontumoral fibroblast cells, and MCF‐7, breast cancer cells using the MTT assay. Compounds 16 and 19 showed lower toxicity against the normal L929 cells. The synthesized compounds’ ( 1–22 ) absorption, distribution, metabolism, and excretion properties were also evaluated. Molecular docking simulations were used to look into the possible binding mechanisms of these inhibitors against AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Turkey.
- Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey.
- Department of Pharmacology, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
- The Rectorate of Bilecik Şeyh Edebali University, Bilecik, Turkey.
ORCID-Profile: Feyzi Sinan Tokalı, Yeliz Demir
Zitieren
APA
Tokalı, F. S., Demir, Y., Türkeş, C., Dinçer, B., & Beydemir, Ş. (2023). Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Drug Development Research, 84(2), 275-295. https://doi.org/10.1002/ddr.22031
Vancouver
Tokalı FS, Demir Y, Türkeş C, Dinçer B, Beydemir Ş. Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Drug Development Research. 2023;84(2):275-295. doi:10.1002/ddr.22031
BibTeX
@article{Tokal2023,
author = {Tokalı, Feyzi Sinan and Demir, Yeliz and Türkeş, Cüneyt and Dinçer, Büşra and Beydemir, Şükrü},
title = {Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors},
journal = {Drug Development Research},
year = {2023},
volume = {84},
number = {2},
pages = {275--295},
doi = {10.1002/ddr.22031}
}
EUVIMED